Comparison of neuroprotective effects of melissa officinalis total extract and its acidic and non-acidic fractions against A β-induced toxicity

Iranian Journal of Pharmaceutical Research

Volumn 12, Issue 2, 2013, Pages 415-423

  Sepand, Mohammad Reza ^a   Soodi, Maliheh ^a   Hajimehdipoor, Homa ^b   Sahraei, Ehsan ^a  

^a TARBIAT MODARES UNIVERSITY   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Beta amyloid; Fractions; Melissa officinalis; Neuroprotection; Oxidative stress

Indexed keywords

ACETYLCHOLINESTERASE; AMYLOID BETA PROTEIN; DICHLORODIHYDROFLUORESCEIN DIACETATE; DICHLOROFLUORESCEIN; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; MELISSA OFFICINALIS EXTRACT; POLYPHENOL DERIVATIVE; REACTIVE OXYGEN METABOLITE; THIOBARBITURIC ACID;

ALZHEIMER DISEASE; ANIMAL CELL; ANTIOXIDANT ACTIVITY; ARTICLE; CELL DEATH; CELL VIABILITY; CHOLINERGIC NERVE CELL; CHOLINESTERASE INHIBITION; COLORIMETRY; CONTROLLED STUDY; CYTOTOXICITY; FLOW CYTOMETRY; IN VITRO STUDY; LIPID PEROXIDATION; MELISSA OFFICINALIS; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PC12 CELL; PLANT LEAF; RAT; SENILE PLAQUE; SPECTROPHOTOMETRY;

EID: 84878917073     PISSN: 17350328     EISSN: 17266890     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Blennow K, de Leon MJ and Zetterberg H. Alzheimer>s disease. Lancet. (2006) 368 (9533) 387-403.
2. Hardy J and Selkoe DJ. The amyloid hypothesis of Alzheimer>s disease: progress and problems on the road to therapeutics. Science. (2002) 297: 353-6.
3. Gandy S. The role of cerebral amyloid beta accumulation in common forms of Alzheimer disease. J. Clin. Invest. (2005) 115: 1121-9.
4. Nathalie P and Jean-Noël O. Processing of amyloid precursor protein and amyloid peptide neurotoxicity. Curr. Alzheimer Res. (2008) 5: 92-9.
5. Butterfield DA, Drake J, Pocernich C and Castegna A. Evidence of oxidative damage in Alzheimer>s disease brain: central role for amyloid beta-peptide. Trends. Mol. Med. (2001) 7:548-54.
6. Y. Oxidative stress and Alzheimer disease. Am. J. Clin. Nutr. (2000) 71:621S-9S.
7. Aliev G, Obrenovich ME, Reddy VP, Shenk JC, Moreira PI, Nunomura A, Zhu X, Smith MA and Perry G. Antioxidant therapy in Alzheimer>s disease: theory and practice. Mini. Rev. Med. Chem. (2008) 8: 1395-406.
8. Schliebs R. Basal forebrain cholinergic dysfunction in Alzheimer>s disease--interrelationship with beta-amyloid, inflammation and neurotrophin signaling. Neurochem. Res. (2005) 30: 895-908.
9. Lane RM, Kivipelto M and Greig NH. Acetylcholinesterase and its inhibition in Alzheimer disease. Clin. Neuropharmacol. (2004) 27: 141-9.
10. Carreiras MC and Marco JL. Recent approaches to novel anti-Alzheimer therapy. Curr. Pharm. Des. (2004) 10: 3167-75.
11. Anekonda TS and Reddy PH. Can herbs provide a new generation of drugs for treating Alzheimer>s disease? Brain. Res. Rev. (2005) 50: 361-76.
12. Zargari AI. Medicinal plants, Tehran University Press, Tehran (1990) 1: 77-81.
13. Naghibi F, Mosaddegh M, Mohammadi Motamed S and Ghorbani A. Labiatae family in folk medicine in Iran: from ethnobotany to pharmacology. Iranian J. Pharm. Res. (2009) 4: 63-79.
14. Dobetsberger C and Buchbauer G. Actions of essential oils on the central nervous system: An updated review. Flavour. Frag. J. (2011) 26: 300-16.
15. Soulimani R, Fleurentin L J, Mortier F, Misslin R, Derrieu G and Pelt JM. Neurotropic action of the hydroalcoholic extract of Melissa officinalis in the mouse. Planta Med. (1991) 57:105-9.
16. Dastmalchi K, Ollilainen V, Lackman P, Boije af Gennas G, Dorman HJ, Jarvinen PP, Yli-Kauhaluoma J and Hiltunen R. Acetylcholinesterase inhibitory guided fractionation of Melissa officinalis L. Bioorg Med. Chem. (2009) 17: 867-71.
17. Pereira RP, Fachinetto R, de Souza Prestes A, Puntel RL, Santos da Silva GN, Heinzmann BM, Boschetti TK, Athayde ML, Bürger ME, Morel AF, Morsch VM and Rocha JB. Antioxidant effects of different extracts from Melissa officinalis, Matricaria recutita and Cymbopogon citratus. Neurochem. Res. (2009) 34: 973-83.
18. Akhondzadeh S, Noroozian M, Mohammadi M, Ohadinia S, Jamshidi AH and Khani M. Melissa officinalis extract in the treatment of patients with mild to moderate Alzheimer>s disease: a double blind, randomised, placebo controlled trial. J. Neurol. Neurosurg Psychiatry (2003) 74: 863-6.
19. Hajimehdipour H, Amanzadeh Y, Sadat Ebrahimi SE and Mozaffarian V. Three Tetraoxygenated Xanthones from Swertia longifolia. Pharm. Biol. (2003) 41: 497-499.
20. Shi da H, Wu JH, Ge HM and Tan RX. Protective effect of hopeahainol A, a novel acetylcholinesterase inhibitor, on hydrogen peroxide-induced injury in PC12 cells. Environ. Toxicol. Pharmacol. (2009) 28: 30-6.
21. Pavlica S and Gebhardt R. Protective effects of flavonoids and two metabolites against oxidative stress in neuronal PC12 cells. Life Sci. (2010) 86: 79-86.
22. Li RC, Pouranfar F, Lee SK, Morris MW, Wang Y and Gozal D. Neuroglobin protects PC12 cells against beta-amyloid-induced cell injury. Neurobiol Aging. (2008) 29: 1815-22.
23. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical biochemistry (1976) 72: 248-254.
24. Wang H and Joseph JA. Quantifying cellular oxidative stress by dichlorofluorescein assay using microplate reader. Free Radic Biol. Med. (1999) 27: 612-6.
25. Ellman GL, Courtney KD, Andres VJr and Feather-Stone RM. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol. (1961) 7: 88-95.
26. Ge YS, Teng WY and Zhang CD. Protective effect of cyclophilin A against Alzheimer>s amyloid beta-peptide (25-35)-induced oxidative stress in PC12 cells. Chin. Med. J. (2009) 122: 716-24.
27. Koh SH, Kwon H, Park KH, Ko JK, Kim JH, Hwang MS, Yum YN, Kim OH, Kim J, Kim HT, Do BR, Kim KS, Kim H, Roh H, Yu HJ, Jung HK and Kim SH. Protective effect of diallyl disulfide on oxidative stress-injured neuronally differentiated PC12 cells. Brain. Res. Mol. Brain Res. (2005) 133: 176-86.
28. Gao X and Tang XC. Huperzine A attenuates mitochondrial dysfunction in beta-amyloid-treated PC12 cells by reducing oxygen free radicals accumulation and improving mitochondrial energy metabolism. J. Neurosci. Res. (2006) 83: 1048-57.
29. Lin YH, Liu AH, Wu HL, Westenbroek C, Song QL, Yu HM, Ter Horst GJ and Li XJ. Salvianolic acid B, an antioxidant from Salvia miltiorrhiza, prevents Abeta(25-35)-induced reduction in BPRP in PC12 cells. Biochem. Biophys. Res. Commun. (2006) 348: 593-9.
30. López V, Martín S, Gómez-Serranillos MP, Carretero ME, Jäger AK and Calvo MI. Neuroprotective and neurological properties of Melissa officinalis. Neurochemical Res. (2009) 34: 1955-1961.
31. Petersen M and Simmonds MS. Rosmarinic acid. Phytochemistry. (2003) 62: 121-5.
32. Alkam T, Nitta A, Mizoguchi H, Itoh A and Nabeshima T. A natural scavenger of peroxynitrites, rosmarinic acid, protects against impairment of memory induced by Abeta (25-35). Behav Brain Res. (2007) 180: 139-45.
33. Iuvone T, De Filippis D, Esposito G, D Amico A and Izzo A.A. The spice sage and its active ingredient rosmarinic acid protect PC12 cells from amyloid-beta peptide-induced neurotoxicity. J. Pharmacol. Exp. Ther. (2006) 317: 1143-9.
34. Liu J. Pharmacology of oleanolic acid and ursolic acid. J. Ethnopharmacol. (1995) 49: 57-68.
35. Novotny L, Vachalkova A and Biggs D. Ursolic acid: an anti-tumorigenic and chemopreventive activity. Minireview. Neoplasma. (2001) 48: 241-6.
36. Wake G, Court J, Pickering A, Lewis R, Wilkins R and Perry E. CNS acetylcholine receptor activity in European medicinal plants traditionally used to improve failing memory. J. Ethnopharmacol. (2000) 69: 105-14.
37. Kihara T, Shimohama S, Sawada H, Kimura J, Kume T, Kochiyama H, Maeda T and Akaike A. Nicotinic receptor stimulation protects neurons against beta-amyloid toxicity. Ann. Neurol. (1997) 42: 159-63.
38. Liu Q and Zhao B. Nicotine attenuates beta-amyloid peptide-induced neurotoxicity, free radical and calcium accumulation in hippocampal neuronal cultures. Br. J. Pharmacol. (2004) 141: 746-54.